Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Outlook Therapeutics | 41O | Sep 19, 2024 | 5.35 | -1.83 |
Outokumpu | OUTA | Sep 19, 2024 | 3.27 | +0.77 |
OUTSURANCE GROUP LTD. | RMQ0 | Sep 19, 2024 | 2.78 | +2.96 |
Ovation Science Inc Common Shares (Canada) | 0VH | Sep 19, 2024 | 0.01 | 0.00 |
Ovb Holding | O4B | Sep 19, 2024 | 18.70 | 0.00 |
Oversea-chinese Banking Corp | OCBB | Sep 19, 2024 | 21.20 | +0.95 |
Oversea-Chinese Banking Corporation Limited | OCBA | Sep 19, 2024 | 10.80 | +2.32 |
Overstock.com, Inc. | OVER | Sep 19, 2024 | 9.67 | +2.37 |
OVH Groupe | 7U7 | Sep 19, 2024 | 5.98 | -0.33 |
OVH GROUPE UNSP.ADR/1/2 | 7U70 | Sep 19, 2024 | 2.70 | +3.85 |
Ovid Therapeutics Inc. | 1OT | Sep 19, 2024 | 0.92 | -4.66 |
Ovintiv Inc. (DE) | 47Q | Sep 19, 2024 | 36.07 | +1.23 |
Ovs SPA | 0OV1 | Sep 19, 2024 | 2.79 | -0.50 |
Ovzon | OVZ | Sep 19, 2024 | 1.37 | +6.55 |
Owens & Minor, Inc. | 6OM | Sep 19, 2024 | 14.20 | 0.00 |
Owens Corning Inc | O5Q | Sep 19, 2024 | 154.25 | +1.75 |
Owl Rock Capital Corporation | 1D6 | Sep 19, 2024 | 13.42 | +1.57 |
OX2 AB | 4DA | Sep 19, 2024 | 5.25 | -0.47 |
OXE Marine | 5LK | Sep 19, 2024 | 0.00 | -70.27 |
Oxford BioDynamics plc | LMQ | Sep 19, 2024 | 0.02 | +6.98 |
Oxford Biomedica | OXOA | Sep 19, 2024 | 4.00 | -0.50 |
Oxford Industries, Inc. | OXD | Sep 19, 2024 | 77.50 | +1.97 |
Oxford Instruments PLC | OX3 | Sep 19, 2024 | 23.80 | -1.65 |
Oxford Lane Capital Corp. | 4RQ | Sep 19, 2024 | 4.67 | +0.50 |
Oxford Lane Capital Corp. - 6.25% Series 2027 Term Preferred | 4RQ0 | Sep 19, 2024 | 21.00 | 0.00 |
Oxford Metrics plc | RNI | Sep 19, 2024 | 0.92 | +0.55 |
Oxford Square Capital Corp. - Closed End Fund | 22T | Sep 19, 2024 | 2.53 | -0.98 |
Oxley Holdings Limited | 8OX1 | Sep 19, 2024 | 0.04 | +3.49 |
Oxurion NV | TG40 | Sep 19, 2024 | 0.56 | 0.00 |
Oxurion NV | TG4 | Sep 19, 2024 | 0.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.